Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥740.3bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥2.84T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥215.8bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥201.3bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥621.6bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥157.3bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥482.3bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥157.8bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥485.3bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥7.16Tat 2024-03-31Cons.Assets IFRS
Total assets¥7.28Tat 2023-12-31Cons.Assets IFRS
Total assets¥6.35Tat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.09Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥3.37Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥4.07Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥3.99Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.83Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥766.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥61.8bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥567.0bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥27.7bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥126.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥341.2bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥270.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥88.582024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥271.692023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥88.572024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥271.632023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio52.6%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-03-31¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-03-31¥322m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥705m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥9.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥6m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥64m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥219.2bn
—segment totalrevenue2024-01-01 → 2024-03-31¥740.1bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥740.0bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥69m
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥225.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 891
ItemContextValueUnit
Payments for purchase of treasury shares fin cf IFRSCurrentYTDDuration-1000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YTDDuration-0JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYTDDuration-99000000JPY
Other fin cf IFRSPrior1YTDDuration0JPY
Other fin cf IFRSCurrentYTDDuration0JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-196398000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-341248000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSPrior1YTDDuration-182442000000JPY
Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRSCurrentYTDDuration-307089000000JPY
Cash and cash equivalents IFRSPrior2YearInstant866885000000JPY
Cash and cash equivalents IFRSPrior1YearInstant1040206000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration-19291000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration33831000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant665152000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant766948000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember604331000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember24925000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember35579000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember664835000000JPY
Revenue from external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember443000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenue from external customers IFRSPrior1YTDDuration665278000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember61000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember-JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember8000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember69000000JPY
Intersegment revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember654000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-723000000JPY
Intersegment revenue IFRSPrior1YTDDuration-JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember604392000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember24925000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember35586000000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember664904000000JPY
Revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1097000000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-723000000JPY
Revenue IFRSPrior1YTDDuration665278000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember225142000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember6924000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember1409000000JPY
Segment profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember233475000000JPY
Segment profit loss IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-10116000000JPY
Segment profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember8000000JPY
Segment profit loss IFRSPrior1YTDDuration223367000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember680981000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember23341000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember35689000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReportableSegmentsMember740011000000JPY
Revenue from external customers IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember322000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenue from external customers IFRSCurrentYTDDuration740333000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass